tirzepatide injection solutions Injections Tirzepatide (Mounjaro & Zepbound) for

Monitoring: What follow-up and monitoring would be involved if I started

SURMOUNT-5 participants who lost at least 5% of their body weight and had less than 5% weight change in the final 12 weeks of the study were invited to continue into the ATTAIN-MAINTAIN phase 3 trial, where participants were randomly assigned 3:2 to once-daily orforglipron (Foundayo, Eli Lilly) or placebo for 1 year

This inflammation is the very thing we are trying to treat

Most of the first week is spent with your body adjusting to these new chemical signals, building a foundation for the higher therapeutic doses that will follow in subsequent months of your treatment plan